A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Is a
Allocation Type
NA
0
Participating Facility
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Interventional Trial Phase
Phase 3
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Sepiapterin
0
Intervention Type
Drug
0
Last Updated
March 8, 2024
0
Masking Type
None (Open Label)
0
Primary Completion Date
February 28, 2031
0
Trial Recruitment Size
56
0
Trial Sponsor
Clinical Trial Start Date
February 29, 2024
0
Study Completion Date
February 28, 2031
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin
0
Official Website
Find more entities like A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.